Nina S Kjellson's Net Worth

$19 Thousand

Estimate Recalculated Nov 11, 2024 07:54AM EST

Who is Nina S Kjellson

Nina S Kjellson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, Invuity, Inc., GLAUKOS Corp, Carbylan Therapeutics, Inc., Trius Therapeutics Inc, Tyra Biosciences, Inc., Panacea Acquisition Corp. II, Eiger BioPharmaceuticals, Inc., Marketo, Inc., Cidara Therapeutics, Inc., Transcept Pharmaceuticals Inc, and Ocera Therapeutics, Inc..

SEC CIK

Nina S Kjellson's CIK is 0001381980

Past Insider Trading and Trends

2016 was Nina S Kjellson's most active year for acquiring shares with 3 total transactions. Nina S Kjellson's most active month to acquire stocks was the month of May. 2013 was Nina S Kjellson's most active year for disposing of shares, totalling 5 transactions. Nina S Kjellson's most active month to dispose stocks was the month of August. 2016 saw Nina S Kjellson paying a total of $0.00 for 62,500 shares, this is the most they've acquired in one year. In 2013 Nina S Kjellson cashed out on 60,302 shares for a total of $483,807.42, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TESARO, Inc.

Investor
Updated Aug 07, 2013
Form 4
-19.53%
-600.00K
Aug 07, 2013
2.47M
Disposition
Aug 05
Form 4
-66.60%
-6.12M
$13.50
Jul 05, 2012
3.07M
Buy-Options
Jul 03
Form 3
Jun 27, 2012
Showing 3 results

EnteroMedics Inc

Investor
Updated Nov 21, 2007
Form 4
Nov 21, 2007
1.55M
Options
Nov 20
Form 4
187.50K
$8.00
$1.50M
Nov 19, 2007
1.55M
Purchase
Nov 15
Form 3
Nov 14, 2007
Showing 3 results

Invuity, Inc.

Investor
Updated Jun 22, 2015
Form 4
4.78%
49.30K
Jun 22, 2015
1.08M
Options
Jun 18
Form 3
Jun 11, 2015
Showing 2 results

Trius Therapeutics Inc

Investor
Updated Sep 13, 2013
Form 4
-100.00%
-60.30K
$8.33
-$483.81K
Sep 13, 2013
Disposition
Sep 11
Form 4
15.00K
May 23, 2013
15.00K
Grant
May 21
Form 4
12.00K
May 24, 2012
12.00K
Grant
May 22
Form 4
12.00K
Jun 06, 2011
12.00K
Grant
Jun 02
Form 4
12.00K
Nov 05, 2010
12.00K
Grant
Nov 03
Form 4
-73.83%
-10.01M
$4.77
Aug 10, 2010
3.55M
Buy-Options
Aug 06
Form 3
Aug 02, 2010
Showing 7 results

GLAUKOS Corp

Investor
Updated Jun 30, 2015
Form 4
Jun 30, 2015
2.60M
Options
Jun 30
Form 3
Jun 24, 2015
Showing 2 results

Tyra Biosciences, Inc.

Investor
Updated Nov 08, 2024
Form 4
-1.75%
-74.58K
$17.22
-$1.28M
Nov 08, 2024
4.19M
Sale
Nov 06 - Nov 07
Form 4
-0.27%
-11.57K
$16.79
-$194.25K
Nov 06, 2024
4.26M
Sale
Nov 04 - Nov 05
Form 4
-1.69%
-138.71K
$16.69
-$2.28M
Nov 01, 2024
8.08M
Sale
Oct 30 - Nov 01
Form 4
18.60K
May 31, 2024
18.60K
Grant
May 29
Form 4
14.50K
Jun 02, 2023
14.50K
Grant
May 31
Form 4
14.50K
Jun 15, 2022
14.50K
Grant
Jun 13
Form 4/A
159.74%
2.71M
Sep 20, 2021
4.41M
Options
Sep 17
Form 4
157.24%
2.71M
Sep 17, 2021
4.44M
Options
Sep 17
Form 3
Sep 14, 2021
Showing 9 results

Panacea Acquisition Corp. II

Investor
Updated Apr 06, 2021
Form 3
Apr 06, 2021
Showing 1 results

Eiger BioPharmaceuticals, Inc.

Investor
Updated Apr 14, 2017
Form 4
10.00K
Apr 14, 2017
10.00K
Grant
Apr 12
Form 4/A
25.00K
Sep 15, 2016
25.00K
Grant
Mar 28
Form 4
25.00K
Apr 01, 2016
25.00K
Grant
Mar 28
Form 3
Mar 31, 2016
1.60M
Showing 4 results

Carbylan Therapeutics, Inc.

Investor
Updated Apr 14, 2015
Form 4
21.26%
810.00K
$5.00
Apr 14, 2015
4.62M
Purchase
Apr 14
Form 3
Apr 08, 2015
Showing 2 results

Marketo, Inc.

Investor
Updated Jun 02, 2014
Form 4
-71.64%
-124.48K
$24.31
-$3.01M
Jun 02, 2014
49.27K
Sale
May 29 - May 30
Form 4
-17.35%
-848.00K
May 30, 2014
4.04M
Disposition
May 28
Form 4
-39.07%
-10.00K
$24.01
-$240.09K
May 22, 2014
15.60K
Sale
May 20 - May 21
Form 4
-36.95%
-15.00K
$22.96
-$344.43K
May 20, 2014
25.60K
Sale
May 16
Form 4
-100.00%
-34.46K
$24.27
-$836.43K
May 15, 2014
Sale
May 13 - May 14
Form 4
-14.63%
-848.00K
May 14, 2014
4.95M
Disposition
May 12
Form 4
-61.95%
-24.42K
$41.96
-$1.02M
Mar 03, 2014
15.00K
Sale
Feb 27 - Feb 28
Form 4
-61.55%
-33.05K
$40.33
-$1.33M
Feb 28, 2014
20.65K
Sale
Feb 26
Form 4
-18.79%
-1.35M
Feb 27, 2014
5.85M
Disposition
Feb 25
Form 4
-100.00%
-4.35K
$40.70
-$177.04K
Feb 18, 2014
Sale
Feb 13
Form 4
-5.89%
-451.49K
Feb 14, 2014
7.21M
Disposition
Feb 12
Form 4
-21.37%
-2.08M
$33.99
-$70.82M
Sep 18, 2013
7.66M
Sale
Sep 18
Form 4
May 22, 2013
9.75M
Options
May 22
Form 3
May 16, 2013
Showing 14 results

Cidara Therapeutics, Inc.

Investor
Updated Apr 22, 2015
Form 4
17.29%
200.00K
$16.00
Apr 22, 2015
1.36M
Purchase
Apr 20
Form 3
Apr 14, 2015
Showing 2 results

Transcept Pharmaceuticals Inc

Investor
Updated Sep 23, 2011
Form 4
12.30%
217.23K
$7.24
$1.57M
Sep 23, 2011
1.98M
Purchase
Sep 21
Form 3
Sep 22, 2011
1.77M
Showing 2 results

Ocera Therapeutics, Inc.

Investor
Updated Dec 11, 2017
Form 4
-100.00%
-65.00K
$1.52
-$19.00K
Dec 11, 2017
Disposition
Dec 11
Form 4
12.50K
Jun 22, 2017
12.50K
Grant
Jun 20
Form 4
12.50K
Jun 15, 2016
12.50K
Grant
Jun 14
Form 4
10.00K
Jun 22, 2015
10.00K
Grant
Jun 18
Form 4
10.00K
Jun 13, 2014
10.00K
Grant
Jun 11
Form 4
20.00K
Dec 23, 2013
20.00K
Grant
Aug 30
Form 4
61.36%
506.69K
Nov 12, 2013
1.33M
Purchase
Nov 08
Form 4
854.09K
$6.03
Jul 17, 2013
854.09K
Purchase
Jul 15
Form 3
Jul 16, 2013
Showing 9 results